GoHealth, Inc. GOCOQ
0.34
0.00
0.00%
as of 28 Jul
- Market cap
- $8.5M
- P/E
- 0.0×
Follow GOCOQ
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.16 | 0.08 | 0.09 | 0.07 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
3.50 | (0.71) | (2.09) | (1.59) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.22 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.78 | |
EV/Sales |
5.15 | 2.29 | 1.12 | 0.97 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 13.89 | |
EV/Operating CF |
(7.67) | (6.79) | (12.11) | (16.71) | |
EV/FCF |
(7.10) | (6.36) | (10.50) | (13.28) | |
Quick Ratio |
1.95 | 1.93 | 1.54 | 1.42 | |
Current Ratio |
2.03 | 2.02 | 1.64 | 1.56 | |
Net Debt/EBITDA |
(24.25) | (26.25) | (2.78) | (9.70) | |
Debt/Assets |
87.40% | 80.34% | 72.87% | 56.10% | |
Debt/Equity |
(6.33) | (12.75) | (108.70) | 2.64 | |
Asset Turnover |
0.13 | 0.29 | 0.62 | 0.64 | |
Operating CF/Net income |
(0.18) | 1.10 | 0.20 | 0.70 | |
Capex/Depreciation |
0.00 | 0.00 | (0.08) | (0.10) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
257.94% | 260.09% | 182.42% | 81.03% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.15 | |
Share Based Compensation of Revenue |
21.55% | 23.78% | 10.23% | (0.14%) | |
Graham Net Nets |
(31.88) | (27.45) | (11.01) | (12.36) | |
Graham Number |
59.76 | 44.67 | 12.84 | 0.00 | |
Earnings Yield |
(1,343.71%) | (858.14%) | (311.20%) | (47.21%) | |
Free Cash Flow Yield |
(453.08%) | (467.97%) | (115.56%) | (100.14%) | |
Revenue per Share |
0.74 | 0.98 | 2.42 | 8.68 | |
Operating CF per Share |
0.43 | (3.02) | (2.31) | (3.49) | |
Capex per Share |
0.00 | 0.00 | (0.17) | (0.26) | |
Free Cash Flow per Share |
0.43 | (3.02) | (2.48) | (3.75) | |
Cash per Share |
2.46 | 2.54 | 2.27 | 3.29 | |
Shareholders Equity per Share |
(7.82) | (4.81) | (0.49) | 25.77 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(7.82) | (4.81) | (0.49) | 25.77 | |
Free Cash Flow |
6.99 | (39.07) | (35.02) | (40.65) | |
Working Capital |
134.67 | 144.29 | 111.78 | 103.80 | |
Capital Expenditures |
— | 0.00 | (2.37) | (2.83) | |
Net Current Asset Value |
(779.71) | (763.80) | (749.93) | (743.17) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.07 | 0.03 | |
Net Profit Margin |
(320.59%) | (281.38%) | (485.13%) | (57.71%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
213.95 | 282.28 | 258.10 | 250.41 | |
Average Payables |
14.38 | 10.76 | 13.57 | 14.98 | |
Average Assets |
1,149.99 | 1,237.90 | 1,185.82 | 1,284.07 | |
Average Common Equity |
135.19 | 171.62 | 169.18 | 303.45 |
Columns are period end dates